1. Li F, Li Z, Han Q, Chen Y, Ji W, Yang Y, Lu S, Xia W*. Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104. Oncogene. 2020; 37:3507–3521.
2. Yan L, Li H*, Xia W*. Bioglass could increase cell membrane fluidity with ion products to develop its bioactivity. Cell Proliferation. 2020;53: e12906.
3. Han Q, Xie QR, Li F, Cheng Y, Wu T, Wong AS, Sha J*, Xia W*. Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer. Theranostics. 2021;11:6526-6541
4. Cheng Y, Lu X, Li F, Chen Z, Zhang Y, Han Q, Zeng Q, Wu T, Li Z, Lu S, Williams C, Xia W*.NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation Protein Cell 2023;14:123-136.
5. Wu T, Zhang Y, Han Q, Lu X, Cheng Y, Chen J, Sha J, Xia W*. Klotho-beta attenuates Rab8a-mediated exosome regulation and promotes prostate cancer progression. Oncogene. 2023;42:2801-2815.
6. Lu X, Han Q, Chen J, Wu T, Cheng Y, Li F, Xia W*. Celery (Apium graveolens L.) Exosome-like Nanovesicles as a New-Generation Chemotherapy Drug Delivery Platform against Tumor Proliferation. Journal of Agriculture and Food Chemistry. 2023; 71:8413-8424.
7. Zhang F, Lu X, Zhu X, Yu Z, Xia W*, Wei X*. Real-Time Monitoring of Small Extracellular Vesicles (sEVs) by In vivo Flow Cytometry. Journal of Extracellular Vesicles. 2024;13:e70003.
8. Guo Z, Xia W*. Isolation of circulating tumor cells: recent progress and future perspectives. Med-X. 2024; 2:28.
9. Chen Z, Ji W, Feng W, Cui J, Wang Y, Li F, Chen J, Guo Z, Xia L, Zhu X, Niu X, Zhang Y, Li Z, Wong AS, Lu S*, Xia W*. PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancer. Science Translational Medicine. 2024 Sep 4;16(763):eadl3598.
10. Xiao H, Xia W*. Hemoglobin-Based Oxygen Carrier: What we have learned and where we are heading? Protein Cell .2026 Mar 24:pwag019.